|
|
|
|
|
|
Tg Therapeuticscmn (TGTX)
|
|
8.425 -0.850 (-9.164%)
|
10/17/2017 4:00pm
|
|
Open:
|
9.400
|
Pre. Close:
|
9.275
|
|
High:
|
9.450
|
Low:
|
8.350
|
|
Volume:
|
2,687,978
|
Market Cap:
|
524.96M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
9.62 - 9.83
|
9.83 - 10
|
|
Low:
|
7.71 - 7.98
|
7.98 - 8.19
|
|
Close:
|
8 - 8.41
|
8.41 - 8.75
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-17 4:43:37 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 12.96  One year: 14.95
|
|
Support:
|
Support1: 8.35 Support2: 6.95
|
|
Resistance:
|
Resistance1:
11.10 Resistance2: 12.80
|
|
Pivot:
|
11.43
|
|
Moving Averages:
|
MA(5): 10.31 MA(20): 11.51
MA(100): 11.44 MA(250): 9.10 
|
|
MACD:
|
MACD(12,26):
-0.47 Signal(12,26,9): -0.12
|
|
%K %D:
|
%K(14,3): 5.77 %D(3): 8.22
|
|
RSI:
|
RSI(14): 19.69
|
|
52-Week:
|
High: 15.350
Low: 4.100 Change(%): 42.8
|
|
Average Vol(K):
|
3-Month: 98043
10-Days 55518
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.TGTX has closed below the lower band by 19.8%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 95.9% wider than normal. The large width of the bands suggest high volatility as compared to TGTX's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Mon, 16 Oct 2017 18:11:15 GMT
Why TG Therapeutics Is Tumbling 15% Today
Mon, 16 Oct 2017 11:26:15 GMT
TG Therapeutics, Inc. Recaps Clinical Data Presentations at the Upcoming 7th ...
Thu, 05 Oct 2017 11:26:15 GMT
TG Therapeutics, Inc. Announces Advancement of its Anti-PD-L1 Monoclonal ...
Mon, 16 Oct 2017 16:07:30 GMT
Oversold Conditions For TG Therapeutics
Fri, 29 Sep 2017 11:26:15 GMT
TG Therapeutics Announces TGR-1202 (umbralisib) Selected For Grant from the ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
